Skip to main content

Month: June 2023

Yara opens digital crop nutrition expertise to third parties

  Over 100 years of crop nutrition knowledge will be made available to third parties with YaraFX Insight to help drive the transition towards more sustainable agriculture. Farmers worldwide can now benefit from these capabilities to increase yields on the digital platform of their choice. Berlin 08.06.2023: Yara International ASA today announced at the 4th World Intelligent Farming Summit, that the company is opening its AgTech portfolio up to third parties through the new agricultural API-solution, YaraFX Insight. The tool will make recommendations based on Yara’s more than 100 years of crop nutrition knowledge, global field trials and over 800 agronomists worldwide, available for integration into third-party digital platforms. – It is crucial that we collaborate to farm more sustainably, reduce global emissions, maximize yields,...

Continue reading

Nexstim provides overview of pilot study results in treatment of severe depression with Nexstim NBT® System at Kuopio University Hospital

Press release, Helsinki, 8 June 2023 at 9 AM (EEST) Nexstim provides overview of pilot study results in treatment of severe depression with Nexstim NBT® System at Kuopio University Hospital Nexstim Plc (NXTMH:HEX) (“Nexstim” or “Company”) provides an overview of results of the pilot study on the use of accelerated iTBS protocol in treatment of severe depression with Nexstim NBT® System at Kuopio University Hospital. The pilot study examined the use of accelerated iTBS protocol in treatment of severe depression with Nexstim NBT® system. Accelerated iTBS means transcranial magnetic stimulation (TMS) therapy where stimulation is given several times per day for one week whereas in conventional TMS therapy stimulation is given once a day for several weeks. Nexstim announces that all patients treated with the accelerated...

Continue reading

Moody’s upgrades Šiaulių Bankas ratings to Baa1

The international rating agency Moody’s Investor Service has upgraded Šiaulių Bankas long-term deposit ratings from Baa2 to Baa1. The outlook on the long-term deposit ratings is affirmed as stable. This is the highest rating in the bank’s history.   “This assessment by one of the largest rating agencies shows that despite uncertainty and a somewhat slowing economy, the consistent and balanced growth strategy of Šiaulių Bankas is paying off. This is an important achievement for us, a confidence-boosting indicator for clients who have entrusted funds to the bank, and a strong signal for investors,” emphasised Vytautas Sinius, Chief Executive Officer of Šiaulių Bankas.  In its statement, Moody’s noted that the key driver for the upgrade of the ratings is the continued strengthening of the bank’s fundamentals, improving profitability, strong...

Continue reading

Boreo acquires health technology company Delfin Technologies

BOREO PLC        INVESTOR NEWS     8 June 2023 at 09:00 EET Boreo acquires health technology company Delfin Technologies Boreo Plc has on June 8, 2023 signed a share purchase agreement to acquire the entire share capital of Delfin Technologies Oy (“Delfin Technologies”, “Delfin” or “the Company”), from Tapani Lahtinen, the Company’s CEO Jouni Nuutinen and a group of private shareholders (“Sellers”). The Company will continue operating after the transaction as part of Boreo’s Electronics Business Area, led by Jouni Nuutinen. “We are delighted to have been provided the opportunity to acquire Delfin Technologies and to partner with the management in the Company’s growth journey. Delfin Technologies is a company led by great people and has a track record of consistently generating high margins and strong returns on capital. Through its attractive...

Continue reading

Annual General Meeting 2023

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss ExchangeGeneva, Switzerland – June 8, 2023 – ObsEva SA (SIX: OBSN), a biopharmaceutical company developing novel therapies for women’s health, today published the invitation to its 2023 Annual General Meeting of Shareholders to be held on June 29, 2023, at 10:30 CEST at the company’s offices in Geneva, Chemin des Aulx 12, 3rd floor, 1228 Plan-les-Ouates, Switzerland. The agenda of the meeting will be as follows: 1      Approval of the Management Report, the Statutory Financial Statements and the Consolidated Financial Statements for Fiscal Year 2022 The Board of Directors proposes that the management report, the statutory financial statements and the consolidated financial statements of ObsEva SA for fiscal year 2022 be approved. 2      Discharge of Liability for...

Continue reading

The rating agency Moody’s affirmed Coop Pank’s Credit rating. Bank deposit rating remained on the level of Baa2 with stable outlook.

Moody’s Investors Service affirmed the credit rating of Coop Pank AS. Investment grade credit rating with a stable outlook was affirmed at the same level as year ago. According to Paavo Truu, CFO of Coop Pank, the confirmation of the credit rating at the current level confirms that the bank has been able to maintain a high quality of the loan portfolio even in difficult times and has shown good profitability. “The confirmation of the rating and stable outlook gives private individuals and businesses additional confidence to become a customer of Coop Pank and keep their money in a domestic financial institution,” said Truu. Ratings affirmed by Moody’s Investors Service for Coop Pank AS:Foreign- and local currency long- and short-term bank deposit rating Baa2/Prime-2 Long- and short-term counterparty risk assessment...

Continue reading

Press release Biocartis Group NV: Disclosure of transparency notification

PRESS RELEASE REGULATED INFORMATION 8 June 2023, 7:00 CEST Disclosure of transparency notification Mechelen, Belgium, 8 June 2023 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), announces today, in accordance with Article 14, paragraph 1 of the Belgian Act of 2 May 2007 on the disclosure of major shareholdings in issuers of which shares are admitted to trading on a regulated market and laying down miscellaneous provisions (the “Belgian Transparency Act”), that on 6 June 2023 it received a transparency notification dated 1 June 2023 indicating that on 25 May 2023 the aggregate number of voting rights and equivalent financial instruments held by Heights Capital Management, Inc. (through CVI Investments, Inc.) decreased below the 3% notification threshold. The...

Continue reading

TGS and SLB Announce Engagement Phase 4 in the U.S. Gulf of Mexico

OSLO, Norway (8 June 2023) – TGS, a global provider of energy data and intelligence, in a strategic collaboration with SLB, today announced the start of the Engagement 4 Ocean Bottom Node (OBN) multi-client acquisition in the U.S. Gulf of Mexico. Acquisition of the 152 OCS block, sparse OBN survey is now underway, extending contiguous data coverage from prior phases into western Green Canyon. In an area known for increasingly challenging subsurface imaging, application of full-waveform inversion (FWI) utilizing ultra-long offsets will provide a dataset that represents a step-change in the conceivable geological and geophysical interpretation. In support of existing leases and future lease sale acreage, fast-track products will be made available in Q4 2023, with final processing completion scheduled for H2 2024. Kristian Johansen, CEO...

Continue reading

Mendus AB: Mendus and NorthX Biologics to enter into strategic cell therapy manufacturing alliance supported by new investor Flerie

Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announces that it has entered into a manufacturing alliance with NorthX Biologics AB (“NorthX”). NorthX is a Contract Development and Manufacturing Organization (CDMO) and serves as the National Swedish Innovation Hub for the GMP manufacture of biologics used in vaccines, gene therapy and other advanced therapy medicinal products (ATMPs). Mendus and NorthX will co-establish cell therapy manufacturing capabilities in Sweden, which will be used for late-stage development and commercial manufacturing of Mendus’ lead asset vididencel. In conjunction with the NorthX collaboration, Mendus has entered into an agreement with Flerie Invest AB (“Flerie”), a leading Swedish investment firm. Flerie will initially invest SEK...

Continue reading

Pixium Vision announces receipt of € 1.8 million from the French Government as Research Tax Credit

Pixium Vision announces receipt of € 1.8 million from the French Government as Research Tax Credit€1.8 million research tax credit received on June 7, 2023, to extend runway to the end of September 2023 Lloyd Diamond participates at the Octane Ophthalmology Tech Forum Edison published an updated analyst report  Paris, France, June 8, 2023 – 07:00 CET – Pixium Vision SA (Euronext Growth Paris – FR0011950641; Mnemo: ALPIX), a bioelectronics company that develops innovative bionic vision systems to enable patients who have lost their sight to live more independent lives, announces today that it has received a € 1.8 million Research Tax Credit. This cash injection will help extend the company’s cash runway until the end of September 2023, providing more flexibility to pursue its longer-term funding needs to support its strategic...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.